Weil Company’s DexCom DXCM Stock Holding History

Weil Company’s Portfolio DXCM Stock Details DXCM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-2,420	Closed	-$325K	–	131
2021 Q4	$325K	Hold	2,420	–	–	0.15%	105
2021 Q3	$331K	Sell	2,420 -860	-26%	-$108K	0.17%	102
2021 Q2	$350K	Sell	3,280 -2,480	-43%	-$238K	0.18%	106
2021 Q1	$518K	Sell	5,760 -740	-11%	-$69.5K	0.29%	77
2020 Q4	$601K	Hold	6,500	–	–	0.36%	66
2020 Q3	$670K	Hold	6,500	–	–	0.49%	49
2020 Q2	$659K	Hold	6,500	–	–	0.56%	40
2020 Q1	$438K	Sell	6,500 -1,080	-14%	-$67.2K	0.41%	52
2019 Q4	$415K	Hold	7,580	–	–	0.32%	65
2019 Q3	$283K	Hold	7,580	–	–	0.21%	79
2019 Q2	$284K	Hold	7,580	–	–	0.23%	82
2019 Q1	$226K	Hold	7,580	–	–	0.19%	91
2018 Q4	$227K	Hold	7,580	–	–	0.21%	87
2018 Q3	$271K	Buy	+7,580	New	+$235K	0.22%	82
2018 Q2	–	Sell	-20,380	Closed	-$378K	–	99
2018 Q1	$378K	Hold	20,380	–	–	0.35%	58
2017 Q4	$292K	Buy	+20,380	New	+$265K	0.27%	70

Other funds holding DXCM

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Sands Capital Management Arlington, Virginia $26.9B AUM 34.44% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return

Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

Weil Company's DXCM Position: Q1 2022 in Review

Weil Company sold out of DexCom (DXCM) in Q1 2022, closing a stake of 2,420 shares — an estimated $325K sold.

Weil Company first reported a position in DXCM in Q4 2017 and held it in 16 quarters. The position peaked at $670K in Q3 2020. 862 funds tracked by Wall St. Rank hold DXCM as of Q1 2022.

Weil Company reported no remaining DexCom position as of Q1 2022 after selling out during the quarter.
Weil Company sold 2,420 DexCom shares in Q1 2022, an estimated $325K.
Weil Company first reported a position in DexCom in Q4 2017 and held it in 16 quarters.
Weil Company's DexCom position peaked at $670K in Q3 2020.
862 funds tracked by Wall St. Rank held DexCom as of Q1 2022.

Based on Weil Company's 13F filing for Q1 2022, filed 6 May 2022.